glp 1 drugs for inflammation Glucagon-like peptide-1: a multi-faceted anti-inflammatory agent GLP-1 Drugs: 6 Things We've
Description
Not medical advice
1 Introduction Childhood obesity has risen dramatically worldwide
doi: 10.1016/j.jamda.2015.10.009
Long-acting, subcutaneously administered, PYY RA are undergoing early phase clinical trials as obesity treatments either alone or in combination with GLP-1 RA (Table 1, NCT02568306 and NCT03574584)
10.1016/j.diabres.2015.07.015 53 SunF.WuS.WangJ.GuoS.ChaiS.YangZ.et al (2015b)
